Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Status:
RECRUITING
Trial end date:
2027-06-30
Target enrollment:
Participant gender:
Summary
A multicenter randomized controlled study of surgery combined with neoadjuvant and adjuvant therapy for locally advanced recurrent nasopharyngeal carcinoma in comparison to surgery combined with adjuvant therapy
Phase:
PHASE3
Details
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Collaborators:
Changhai Hospital Fujian Medical University Union Hospital People's Hospital of Guangxi Zhuang Autonomous Region Shanghai 6th People's Hospital Shanghai Zhongshan Hospital Shenzhen Second People's Hospital
Treatments:
Control Groups Endoscopy Neoadjuvant Therapy toripalimab